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http://www.biomedcentral.com/1756-0500/5/496RESEARCH ARTICLE Open AccessPre-existing diabetes mellitus and adverse
pregnancy outcomes
Hayfaa A Wahabi1*, Samia A Esmaeil1, Amel Fayed2,3, Ghadeer Al-Shaikh4 and Rasmieh A Alzeidan1Abstract
Background: Pregnancies complicated by pre-existing diabetes mellitus (PDM) are associated with a high rate of
adverse outcomes, including an increased miscarriage rate, preterm delivery, preeclampsia, perinatal mortality and
congenital malformations; compared to the background population. The objectives of this study are to determine
the prevalence of PDM and to investigate the maternal and the neonatal outcomes of women with PDM.
Methods: This is a retrospective cohort study for women who delivered in King Khalid University Hospital (KKUH)
during the period of January 1st to the 31st of December 2008. The pregnancy outcomes of the women with PDM
were compared to the outcomes of all non-diabetic women who delivered during the same study period.
Results: A total of 3157 deliveries met the inclusion criteria. Out of the study population 116 (3.7%) women had PDM.
There were 66 (57%) women with type 1 diabetes mellitus (T1DM) and 50 (43%) women with type 2 diabetes mellitus
(T2DM). Compared to non-diabetic women those with PDM were significantly older, of higher parity, and they had
more previous miscarriages. Women with PDM were more likely to be delivered by emergency cesarean section (C/S),
OR 2.67, 95% confidence intervals (CI) (1.63-4.32), P < 0.001, or elective C/S, OR 6.73, 95% CI (3.99-11.31), P < 0.001. The
neonates of the mothers with PDM were significantly heavier, P < 0.001; and more frequently macrosomic; OR 3.97,
95% CI (2.03-7.65), P = 0.002. They more frequently have APGAR scores <7 in 5 minutes, OR 2.61, 95% CI (0.89-7.05),
P 0.057 and more likely to be delivered at <37 gestation weeks, OR 2.24, 95% CI (1.37- 3.67), P 0.003. The stillbirth rate
was 2.6 times more among the women with PDM; however the difference did not reach statistical significance, P 0.084.
Conclusion: PDM is associated with increased risk for C/S delivery, macrosomia, stillbirth, preterm delivery and low
APGAR scores at 5 min.
Keywords: Pre-existing diabetes mellitus, Macrosomia, Stillbirth, Cesarean delivery, Preterm deliveryBackground
It is estimated that by the year 2030 more than 360 mil-
lion people will have diabetes mellitus (DM) [1] and as
the burden of the disease increases the management of
pregnancies complicated by DM will be part of the daily
obstetric practice in many regions of the world. Studies
investigating the influence of ethnicity on the outcome
of pregnancies complicated by pre-existing diabetes
mellitus (PDM) reported variation in the outcome with
different ethnic groups with worse outcome for Asian
[2] and Afro-Caribbean mothers compared to Caucasian* Correspondence: umlena@yahoo.com
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reproduction in any medium, provided the or[3], however this difference might be explained by access
to and utilization of preconception and prenatal care [3].
The physiological changes of pregnancy put the
human body in a state of carbohydrate intolerance. The
pregnancy specific hormones, such as human placental
lactogen and the increased levels of cortisol and prolac-
tin, increase the resistance to insulin and call for more
production of the hormone to maintain homeostasis of
blood glucose during pregnancy [4]. Such demand is not
met in pregnant diabetic women due to the pathology
associated with diabetes.
Pregnancies complicated by diabetes are associated with
a high rate of miscarriage, preterm delivery, preeclampsia,
perinatal mortality and congenital malformations com-
pared to the background population [5,6]. A recent sys-
tematic review showed that pregnancies complicated byl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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perinatal mortality and neonatal mortality than those
complicated by type 1 diabetes mellitus (T1DM) [7].
Many diabetes associated complications such as con-
genital malformations are due to the effect of maternal
hyperglycemia on the developing embryo during the
early weeks of conception [8], thus preconception care
including normalization of blood glucose, folic acid sup-
plementation and detection and treatment of diabetic
vascular complications, has significantly improved the
rate of congenital malformations, perinatal mortality and
preterm delivery [9]. Close monitoring and normalization
of blood glucose for pregnant women with T1DM and
T2DM significantly improve the perinatal mortality and
the stillbirth rate [10].
The objectives of this study are to determine the
prevalence of PDM and to investigate the maternal and
the neonatal outcomes of women with PDM.
Methods
This is a retrospective cohort study to investigate the
maternal and the neonatal outcomes of diabetic women
with PDM (type 1 and type 2) who were admitted to the
labour ward in King Khalid University Hospital (KKUH)
for delivery as compared to the non-diabetic women
delivered during the same period.
In KKUH maternity unit, women with PDM follow a
specific course of treatment including nutritional ther-
apy, self-monitoring of blood glucose level and antenatal
fetal surveillance. All women with T2DM, who used oral
hypoglycemic agents when not pregnant, are shifted to
insulin during pregnancy. Insulin therapy is adjusted to
maintain the fasting and pre-prandial blood glucose at
≤5.9 mmol/l (106 mg/100 ml) and the 1 h postprandial
glucose at < 7.8 mmol/l (140 mg/dl) [11].
The data for this study were collected for the period of
12 months from the 1st of January to the 31st of Decem-
ber 2008 from the labour ward registry and the missing
data were obtained from the maternal medical records.
The inclusion criteria for this study were:
1. Gestation age of 24 weeks or more at the time of
delivery, calculated from the last menstrual period
and/or early ultrasound scan.
2. Singleton pregnancy.
3. Women diagnosed with either T1MD or T2DM
before the index pregnancy (study group).
4. Women with neither PDM nor gestational diabetes
(GDM) (control group).
The demographic characteristics and the pregnancy
outcomes of the women with PDM were compared to
the outcomes of all non-diabetic women who delivered
during the same study period. Women with multiplepregnancies and those diagnosed with GDM were
excluded from the analysis of the outcomes; however all
deliveries more than 24 weeks were considered when
calculating the prevalence rate of PDM. Further analysis
was done to compare the outcomes of pregnancies com-
plicated with T1DM and T2DM. The maternal variables
we assessed were; age, gravidity, parity, gestation age at
delivery, mode of delivery, premature delivery at less
than 37 weeks of gestation and previous history of mis-
carriage. The neonatal outcomes included birth weight,
macrosomia (birth weight ≥ 4 kg) and APGAR scores at
5 min after delivery and the prevalence of intra-uterine
fetal death (IUFD).
Statistic analysis
We compared means using the Student t test for con-
tinuous variables after assessing normality distribution
of the variables, and Chi squire for categorical variables.
Data were analyzed using Statistical Package for the So-
cial Sciences (SPSS), Version 17 (SPSS Inc., Chicago, IL,
USA). Odds Ratio (OR) was calculated and P-value of
less than 0.05 was considered significant. Outcomes for
macrosomia and mode of delivery were adjusted for ma-
ternal age and parity using regression analysis.
Ethical approval was sought and granted before com-
mencing the study from the institutional ethics review
board of King Saud University Medical College.
Results
There were 3273 deliveries during the study period of
which 3157 met the inclusion criteria. Of the study
population 116 (3.7%) women had PDM and 569 had
GDM (18.0%) while 2472 (78.3%) were not diabetic. For
outcomes analysis, the 2472 non-diabetic women were
compared to the 116 women in the PDM group.
There were 66 (57%) women with T1DM and 50 (43%)
women with T2DM. All women with PDM received
insulin during pregnancy to reach the target blood glu-
cose levels.
The comparisons of the demographic characteristics of
the women with PDM and non-diabetic women are
shown on Table 1. The diabetic mothers were signifi-
cantly older; they had significantly more pregnancies and
of significantly higher parity, in addition significantly
more of the diabetic women had previous miscarriages
compared to the non-diabetic women. Compared to the
non-diabetic group the women with PDM were nearly
threefold more likely to be delivered by emergency
cesarean section (C/S), OR 2.67, 95% confidence inter-
vals (CI) (1.63-4.32), P < 0.001, and more than six fold
more likely to deliver by elective C/S, OR 6.73, 95% CI
(3.99-11.31), P < 0.001 (Table 2). The neonates of the
mothers with PDM were significantly heavier when com-
pared to those of the non-diabetic mothers, P < 0.001;
Table 1 Comparison of maternal demographic
characteristics between non-diabetic women, and women







Maternal age 28.62 ± 5.98 34.95 ± 5.66 < 0.001
Gravidity 3.58 ± 2.78 6.43 ± 3.46 < 0.001
Parity 2.06 ± 2.28 4.53 ± 2.90 < 0.001
History of previous
miscarriage
786 (31.8) 54 (46.6) 0.002
Data expressed as means ± standard deviation or n (%).
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fourfold for the neonates of the PDM group OR 3.97,
95% CI (2.14-7.40), P < 0.001. The mean gestational age
at delivery for mothers with PDM was significantly less
than the non-diabetic mothers 38.67 ± 2.295 versus 37.28 ±
2.812, P < 0.001. There was twofold increase in preterm de-
livery less than 37 gestation weeks, OR 2.24, 95% CI (1.37-
3.67), P = 0.003 (Table 2). Although there was a threefold
increase in the odds for low APGAR scores among the
neonates of the mothers with PDM compared to non dia-
betics, OR 2.61, 95% CI (0.89- 7.05); the difference did not
reach statistical significance, P = 0.057. Similarly, despite
the increase in frequency of intra-uterine fetal death (IUFD)
among women with PDM compared to non-diabetic
women, the difference did not reach statistical significance,
P = 0.084; however the OR of 2.62, 95% CI (0.78-7.96) was
consistent with more than twofold increase (Table 2).
After adjustment for maternal age and parity, women
with PDM continued to show significantly higher odds
for C/S delivery OR =3.5, 95% CI; (2.34-5.24), P <0.001
and macrosomia OR = 2.71, 95% CI; (1.41-5.21),
P <0.001 than non-diabetic women.
There were no significant differences in the outcomes
between pregnancies complicated by T1DM and T2DM
except for the previous miscarriage which was significantly
more frequent among women with T2DM; P = 0.015
(Table 3).Table 2 Comparison of maternal and perinatal outcomes betw
diabetes mellitus
Characteristic Non-diabetic 2472 (95.5) Pr
Emergency C/S 340 (13.8)
Elective C/S 125 (5.1)
APGAR scores at 5 min <7 42 (1.7)
Birth weight 3120.14 ±578.18
Macrsomia 76 (3.1)
IUFD 32 (1.3)
Mean gestation age at delivery (weeks) 38.67 ± 2.295
Delivery < 37 weeks 222 (9)
OR = Odd Ratio, CI = Confidence intervals, C/S = Cesarean section, IUFD = Intra-uterDiscussion
The prevalence of PDM in this study is 3.7% which indi-
cates a fivefold increase during the last 14 years based
on earlier studies from Saudi Arabia [12,13]. This notice-
able rise in the prevalence of PDM during pregnancy
could be explained in part by the improved screening
and detection of diabetes, however the main cause in
our opinion is the increased prevalence of T2DM among
adults in the Saudi population to an estimated range of
21to 23% [14]. It is worth noting that the prevalence of
3.7% for PDM is very high compared to other regions
of the world [6,15-17].
Our results confirm the findings by other investigators
about the demographic characteristics of the diabetic
pregnant women. In this study women with PDM are
older and of higher parity when compared to non-
diabetic pregnant women [12]. Moreover diabetic
women have poorer reproductive performance including
an increased rate of miscarriage which concurred with
the findings in similar cohort [18,19].
We observed a threefold increase in the rate of
APGAR scores less than 7 at 5 min of birth on the dia-
betic women compared to the non-diabetic. In a recent
report low APGAR scores are predictors of long term
neurological disabilities [20]. Such low scores in the dia-
betic cohort could be explained by the increase risk of
birth asphyxia due to placental angiopathy [21].
Our results indicated that infants of diabetic mothers
had significantly higher birth weight compared to those
of non-diabetic mothers; moreover 11% of the infants
delivered to the diabetic mothers were macrosomic com-
pared to 3% of those delivered to non-diabetic mothers
(Table 2). Uncontrolled maternal hyperglycemia ad-
versely influences fetal weight and growth with resultant
macrosomia at moderately elevated levels and intra-
uterine growth restriction at very high levels of maternal
blood glucose [21]; however PDM is not the only factor
which causes fetal macrosomia other factors including
maternal age over 30 years, prolonged pregnancy, multi-
parity [22] and maternal obesity were proven to play aeen non-diabetic women, and women with pre-existing
e-existing Diabetes Mellitus 116 (4.5) OR (95%CI) P value
28 (24.1) 2.67(1.64-4.32) < 0.001
26 (22.4) 6.73(3.99-11.31) < 0.001
5 (4.3) 2.61(0.89-7.05) 0. 057
3227.34 ± 804.88 < 0.001
13 (11.2) 3.97 (2.14-7.40) < 0.001
4 (3.4) 2.62 (0.78-7.96) 0.084
37.28 ± 2.812 <0.001
21(18.1) 2.24 (1.37- 3.67) 0.003
ine fetal death. Data expressed as means +/- standard deviation or number (%).
Table 3 Maternal characteristic and outcomes of
pregnancy complicated with type 1 and type 2 diabetes
mellitus
Pregnancy outcomes T1DM n = 50 T2DM n = 66 P value
Maternal age (years) 34.44 ± 6.142 35.33 ± 5.298 0.403
Parity 4.04 ± 3.221 4.89 ± 2.603 0.119
Birth weight (gms) 3223.08 ± 856.193 3230.58 ± 770.400 0.961
Previous miscarriage 17(14.7) 37(31.9) 0.015
Cesarean section
delivery
26 (22.4) 28 (24.1) 0.350
APGAR scores at
5 min <7
3 (2.6) 2 (1.7) 0. 651
Macrsomia 6 (5.2) 7 (6.0) 1.0
IUFD 2 (1.7) 2 (1.7) 1.0
Delivery < 37 weeks 9 (7.8) 12(10.3) 1.0
Data presented as mean ± standard deviation or number and percentage,
IUFD = Intrauterine fetal death.
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associated with significant maternal and perinatal com-
plications including increased rate of C/S, birth asphyxia
and perinatal mortality [24].
The results of this study showed that almost 50% of
women with PDM had C/S delivery; while the corre-
sponding figure for non-diabetic women was less than
20%. This finding agrees with that observed by other
investigators [12,15]. The reason behind the tendency
towards delivery by C/S is in great part attributed to the
increased rate of macrosomia among women with PDM,
however significant association was found between the
risk of C/S delivery in diabetic women and maternal
obesity, uncontrolled diabetes and unplanned pregnancy
[25]. Recent reports found that with the increase rate of
elective C/S there was improvement in the rate of shoul-
der dystocia and its associated morbidities [26] as well
as APGAR scores at 5 min [27], nevertheless the effect-
iveness and cost effectiveness of the approach of screen-
ing for macrosomia by ultrasound scanning, fetal weight
estimation and subsequent delivery by elective C/S was
doubted by other investigators [28].
Concurrent with our results is a recent report which
confirmed that the rate of both iatrogenic and spontan-
eous preterm deliveries are increased in mothers who
are diabetic, compared to the background population
[29] nevertheless, premature infants of diabetic mothers
do not seem to be at risk of complications more than
the preterm infants of non-diabetic mothers [30].
The stillbirth rate among the women with PDM was
almost threefold increased compared to the non-diabetic
cohort (Table 2). Recent review on the causes of peri-
natal mortality in women with PDM showed that ante-
partum asphyxia and congenital abnormalities were the
leading two causes of stillbirth [21]. Placental angiopathysecondary to uncontrolled maternal hyperglycemia was
suggested as an etiology for antenatal asphyxia [21] and
peri-conception uncontrolled hyperglycemia as the cause
of congenital abnormalities [9].
Contrary to the findings by Murphy et al. [31], we did
not find significant differences in the maternal character-
istics or the outcomes of pregnancies complicated by
T1DM compared to those complicated by T2DM except
for the history of previous miscarriage (Table 3). This
might be due to the small number of women with
T1DM and T2DM in this study.
The importance of this study is that it investigated a
key public health problem which is PDM and that it
gives preliminary indicators about its prevalence and im-
pact on pregnancy outcome in the Kingdom of Saudi
Arabia, such information is imperative for practice and
research considering the paucity of data about the repro-
ductive outcome of diabetic pregnancy.
We are aware of the limitation of this study including
the retrospective nature of the design and the lack of
data on important confounding factors which could have
influenced the outcome such as maternal pre-pregnancy
weight and weight gain during pregnancy, as well as im-
portant outcomes such as preeclampsia, congenital mal-
formations and perinatal mortality. Other limitations
include a single centre experience which might hinder
the extrapolation of the results to other regions of
the Kingdom, however, our results are consistent
with the national epidemiological studies on T2DM in
the Kingdom.The implication to practice
Because of the documented high prevalence of T2DM in
the Saudi population we recommend that all pregnant
women be screened early in pregnancy (during the first
trimester) using fasting blood glucose to identify women
with PDM [32]. Close monitoring and adjustment of in-
sulin therapy based on daily self-monitoring of blood
glucose with clear target of blood glucose level values
for fasting and postprandial and periodically assessed
hemoglobin A1C levels, is imperative for improving the
outcomes for women with PDM [33].Implication to research
The results of this study showed that 3.7% of women
giving birth every year in KKUH have PDM and an esti-
mated 18% develop GDM, all these mothers and their
offspring are at risk of adverse pregnancy outcomes.
This high prevalence in one health institution calls for a
national prospective survey to estimate the prevalence of
PDM in the different regions of the Kingdom and to
evaluate the national impact of the disease on the mater-
nal and perinatal outcomes. Such a survey will provide
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ive health services provision.
Conclusion
The prevalence of PDM in KKUH is among the highest
in the world. PDM is associated with increased risk for
C/S delivery, macrosomia, stillbirth, preterm delivery
and low APGAR scores at 5 min.
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